Olanzapine increases plasma ghrelin level in patients with schizophrenia-Reference-Cited by-同舟云学术

Olanzapine increases plasma ghrelin level in patients with schizophrenia

Published:2005-01 Issue:1 Volume:30 Page:106-110
ISSN:0306-4530
Container-title:Psychoneuroendocrinology
language:en
Short-container-title:Psychoneuroendocrinology

Author:

Murashita Mari,Kusumi Ichiro,Inoue Takeshi,Takahashi Yoshito,Hosoda Hiroshi,Kangawa Kenji,Koyama Tsukasa

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Reference18 articles.

1. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans;Ariyasu;J. Clin. Endocrinol. Metab.,2001

2. Delayed short-term secretory regulation of ghrelin in obese animals: evidence by a specific RIA for the active form of ghrelin;Ariyasu;Endocrinology,2002

3. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic patients treated with olanzapine;Gothelf;Am. J. Psychiatr.,2002

4. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue;Hosoda;Biochem. Biophys. Res. Commun.,2000

5. Olanzapine therapy and changes in body weight and blood glucose levels among patients with schizophrenia—Interim report of a prospective post-marketing special study of olanzapine conducted in Japan;Ito;Jpn. J. Clin. Psychopharmacol.,2003

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allyl isothiocyanate, a TRPA1 agonist, protects against olanzapine-induced hypothalamic and hepatic metabolic aberrations in female mice;Biochemical Pharmacology;2024-04

2. Weight Gain is Not Associated with Antipsychotic Medication, Sociodemographic Factors, or Diagnosis in a Welsh Secure Mental Health Unit;International Journal of Forensic Mental Health;2023-06-02

3. Eating cognitions, emotions and behaviour under treatment with second generation antipsychotics: A systematic review and meta-analysis;Journal of Psychiatric Research;2023-04

4. Multicentre, randomised, double-blind, placebo-controlled phase II study of prophylactic olanzapine for patients with metastatic breast cancer receiving T-DXd treatment: protocol for the ERICA study (WJOG14320B);BMJ Open;2023-04

5. Modulation of hypothalamic AMPK phosphorylation by olanzapine controls energy balance and body weight;Metabolism;2022-12